Roche signs drug discovery pact with Chinese biotech Defand for molecular glues

Roche has entered a drug discovery collaboration with Chinese biotech Defand Therapeutics, targeting molecular glue medicines. The deal signals continued Western pharma interest in Chinese innovation despite geopolitical tensions. Financial terms and specific targets are undisclosed, leaving scope and strategic intent partially unclear.